Genetic Polymorphisms in the Transforming Growth Factor-β Signaling Pathways and Breast Cancer Risk and Survival
The transforming growth factor (TGF)-β signaling pathway plays a critical role in breast cancer development and progression. Limited data from human studies, however, are currently available to link biomarkers in this pathway directly to the risk and survival of breast cancer. Most of the previous epidemiologic studies have focused on evaluating polymorphisms in the TGFB1 gene (T+29C , rs1982073) and the TGFBR1 gene (9A/6A), and the results have been inconsistent. The present review summarizes epidemiologic evidence regarding the association of genetic polymorphisms in the TGF β pathway genes with breast cancer risk and survival and provides rationale and new approaches to continuing the research in this area.
- Microtiter Plate Technique for the Measurement of Glutathione in Fresh and Cryopreserved Lymphoblasts Using the Enzyme Recycling
- p53 Detection in Breast Cancer
- Tumor-Infiltrating Lymphocytes and Their Significance in Melanoma Prognosis
- The Detection of Chromosomal Translocations Involving the Immunoglobulin Loci in B-Cell Malignancies
- Analysis of Tumor-Associated Mucin Glycotopes by Western Transfer Methods
- Monitoring Methylation and Gene Expression in Cancer
- [D-Arg6, D-Trp7,9, NmePhe8]-Substance P (6-11) Activates JNK and Induces Apoptosis in Small Cell Lung Cancer Cells via an Oxidan
- Sphere-Forming Assays for Assessment of Benign and Malignant Pancreatic Stem Cells
- MHC 四聚体助力细胞治疗基础研究:CTL 表位筛选
- FLT3 Mutations in Acute Myeloid Leukemia